PICTURE_ONCOLOGY%20INNOVATION%20SUMMIT_e
Bio Health sector innovations targeting oncology. Novel therapies, platforms & technologies.
Partnering, Licensing & Business Development, what industry is looking for.
 
VC & Investment, who is funding what.
Engage with key partners, globally.
From the lab & the clinic, a selection of world-class innovations, technology transfer assets and leading companies - selected by industry & investment KOLs, not by registration fee.
REGISTRATION IS FREE FOR INNOVATION STAKEHOLDERS
 Key themes & discussion topics include:
Industry collaborations - what pharma & industry want
Health System innovation needs
Government, grant funding & innovation programs
Venture Capital & investment
Roundtables & workshops 

Oncology innovations from translational research to the clinic.
Keynotes from leading institutes, Investor panels with active oncology investors, networking & engagement with innovation stakeholders from research, technology transfer & licensing, startup & growth companies, industry & investors worldwide. 

 
SPEAKERS

Salgaller NCI.jpeg

Michael Salgaller

Supervisor, Invention Development and Marketing Unit (IDMU),Technology Transfer Center, National Cancer Institute

Jeroen Bakker, Novo Seeds.jpeg

Jeroen Bakker

Principal,

Novo Seeds / Novo Holdings

McCracken Nextech.jpeg

Melissa McCracken

Principal,

Nextech Invest

Alice Lin Pomponio.jpeg

Alice Lin Pomponio

Managing Director

BrightEdge Philanthropic Impact Fund,

American Cancer Society

Tony hickson.jpg

Tony Hickson

Chief Business Officer

Cancer Research UK

Kevin%20Noonan_edited.jpg

Kevin Noonan

Partner, Chair of the Biotechnology &  Pharmaceuticals Practice Group, MBHB LLP

Matthew Miessau Epidarex.jpeg

Matthew Miessau

Associate,

Epidarex Capital

Prof. Andrew Scott

Research Translation & Commercialisation Lead, Victorian Comprehensive Cancer Centre (VCCC)

Peter Neubeck Kurma.jpeg

Peter Neubeck

Partner,

Kurma Partners 

Alejo Advent France.jpeg

Alejo Chorny

Operating Partner,

Advent France Biotechnology

Youssef Bennani CTI.jpeg

Youssef Bennani

Managing Partner

CTI Life Sciences Fund

Scott photo.png

AGENDA

July 12

10:00 EDT

  • Welcome & Opening Remarks 

    • Christian J. Suojanen - CEO, Broadreach Global

10:05 EDT

  • Addressing the Grand Challenges in Cancer Research & Innovation

    • Tony Hickson, Chief Business Officer, Cancer Research UK

10:45 EDT

  • ViroStatics - Company Presentation

    • Franco Lori, Chief Executive Officer​

July 13

10:00 EDT

  • Welcome & Opening

10:15 EDT

  • Partnering with the National Cancer Institute

    • Michael Salgaller, Supervisor, Invention Development and Marketing Unit (IDMU),Technology Transfer Center, National Institutes of Health / National Cancer Institute

10:45 EDT

  • Investor Session I - What are active oncology focused investors looking for? What technologies, approaches & criteria will attract investments?

    • Jeroen Bakker, Principal, Novo Sooeds / Novo Holdings

    • Peter Neubeck, Partner, Kurma Partners

    • Alejo Chorny, Operating Partner, Advent France Biotechnology

    • Alice Lin Pomponio, Managing Director, BrightEdge Impact Fund, American Cancer Society

11:45 EDT

  • Deka Biosciences - Company Presentation

    • Pavel Khrimian, Chief Business Officer​

July 14

10:00 EDT

  • Opportunities in Research Translation in Oncology.

    • Professor Andrew Scott, Research Translation & Commercialisation Lead, Victorian Comprehensive Cancer Centre (VCCC)

10:45 EDT

  • Investor Session II - Funding & building companies to transform cancer treatment

    • Melissa McCracken, Principal, Nextech Invest

    • Matthew Miessau, Associate, Epidarex Capital

    • Youssef Bennani, Managing Partner, CTI Life Sciences Fund

11:30 EDT

  • Protecting Oncology IP in the US - Developments & Strategies

    • Kevin Noonan, Partner, Head of the Biotechnology & Pharmaceutical Practice Group, MBHB LLP

July 15

10:00 EDT

  • Roundtable Discussion Panel​

10:45 EDT

  • Ability Pharma - Company Presentation

    • Carles Domenech, Executive Chairman & Chief Scientific Officer​

11:10 EDT

  • Scenic Biotech - Company Presentation

    • Sebastian Nijman & Chief Scientific Officer​

11:10 EDT

  • ImCare Biotech - Company Presentation

    • Mina Soryal, Director, Commercial Strategy & Corporate Development